GENERAL EMBOLICS

Device Boston Scientific Corporation
Total Payments
$86,419
Transactions
540
Doctors
317
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2020 $9.15 1 1
2019 $86,410 539 316

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $61,025 2 70.6%
Food and Beverage $24,973 534 28.9%
Travel and Lodging $421.20 4 0.5%

Payments by Type

Research
$61,025
2 transactions
General
$25,394
538 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
DELTIC for Intrahepatic Cholangiocarcinoma Boston Scientific Corporation $50,000 0
Drug Eluting Beads for HCC Boston Scientific Corporation $11,025 0

Top Doctors Receiving Payments for GENERAL EMBOLICS — Page 13

Doctor Specialty Location Total Records
, M.D Diagnostic Radiology Savannah, GA $11.79 1
, MD Diagnostic Radiology Hilton Head Island, SC $11.57 1
, MD Internal Medicine Cincinnati, OH $11.32 1
, M.D Diagnostic Radiology Cincinnati, OH $11.29 1
, M.D Diagnostic Radiology Cartersville, GA $11.23 1
, M.D Student in an Organized Health Care Education/Training Program Cincinnati, OH $11.22 1
, MD Diagnostic Radiology Bowling Green, KY $11.22 1
, M.D Vascular & Interventional Radiology San Diego, CA $11.22 1
, M.D Vascular & Interventional Radiology Lubbock, TX $11.21 1
, M.D Vascular & Interventional Radiology Louisville, KY $11.08 1
, M.D Nephrology Hurst, TX $10.81 1
, M.D Diagnostic Radiology Greenville, SC $10.67 1
, MD Specialist New York, NY $10.01 2
, MD Diagnostic Radiology Akron, OH $9.90 1
, M.D Internal Medicine Southgate, MI $9.15 1
, M.D Vascular Surgery Mobile, AL $8.75 1
, MD Vascular Surgery Bangor, ME $5.78 1
, MD Diagnostic Radiology Albuquerque, NM $5.60 1

About GENERAL EMBOLICS

GENERAL EMBOLICS is a device associated with $86,419 in payments to 317 healthcare providers, recorded across 540 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.

Payment data is available from 2019 to 2020. In 2020, $9.15 was paid across 1 transactions to 1 doctors.

The most common payment nature for GENERAL EMBOLICS is "Unspecified" ($61,025, 70.6% of total).

GENERAL EMBOLICS is associated with 2 research studies, including "DELTIC for Intrahepatic Cholangiocarcinoma" ($50,000).